Hair follicle drug tests can detect cannabis use over a 90-day period by analysing THC-COOH trapped in hair shaft segments as they grow. They are the most controversial form of dru
As hair grows, THC and its metabolites are deposited in the hair shaft from blood flowing through the follicle. Laboratories typically analyse the proximal 1.5 inches (3.8 cm) of hair, representing approximately 90 days of growth at the average rate of 0.5 inches per month. The primary target compound is THC-COOH embedded in the hair cortex, detected via ELISA screening and LC/MS/MS confirmation. Hair colour and texture significantly affect metabolite deposition — melanin binds THC preferentially, creating well-documented racial disparities. Understanding the endocannabinoid system helps contextualise why fat-soluble cannabinoids are deposited in hair.
The widely-cited 90-day window applies only to the top 1.5 inches of hair growth. Very recent use (within the past 5–10 days) may not be detected because hair requires time to grow out of the follicle. This creates a paradox: hair tests miss very recent use that urine tests catch. The urine drug test remains more reliable for detecting use within the past month. For casual users, hair tests may not be sensitive enough to register occasional use — some studies show false-negative rates exceeding 50% for light cannabis use.
Multiple peer-reviewed studies, including ACLU-cited research, demonstrate that hair follicle tests produce disproportionately positive results for Black individuals compared to white individuals with identical self-reported cannabis use. This bias stems from melanin binding THC-COOH more efficiently in darker hair. External contamination from cannabis smoke has also been documented, raising questions about whether the test detects ingestion or environmental exposure. The ACLU has documented extensive concerns about hair test fairness in criminal justice contexts.
Hair follicle tests are primarily used by federal law enforcement, some Fortune 500 companies, and regulated transportation industries for long-term use detection. They are not SAMHSA-mandated for federal workplace testing (SAMHSA has proposed but not finalised hair testing guidelines). Several US cities including New York City have restricted or banned pre-employment hair testing. Before accepting results, understand how THC differs from CBD in terms of what triggers a positive. False positive protocols remain inadequately standardised for hair testing.